Libbe L Englander, Ph.D. founded Pharm3r in 2011 to apply computer science and predictive analytics to the evaluation of medical products, researchers, clinical trials and companies. Pharm3r integrates disparate databases from governmental sources to social media and provides strategic insights and risk analysis. Pharm3r’s clients include firms in the insurance, pharmaceutical, medical device and healthcare delivery industries. Prior to Pharm3r Libbe founded, ran and successfully sold a healthcare hedge fund. The fund utilized her scientific expertise and drew on her experience managing a healthcare competitive intelligence and advisory firm. Libbe has a Ph.D. in Molecular Biology from The Rockefeller University and a B.S. in Biology from Yale University.